GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development

The Guardian28 Jul 2026Macro
Automatically composed with AI from the cited sources

No desk note for this article — the source text is below.

Pharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site